UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

COVID-19 infection in people living with HIV

British medical bulletin, 2023-09, Vol.147 (1), p.20-30

2023

Volltextzugriff (PDF)

Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial

Clinical infectious diseases, 2023-02, Vol.76 (3), p.398-407

2023

Volltextzugriff (PDF)

Viral meningitis

British medical bulletin, 2005, Vol.75-76 (1), p.1-14

CHADWICK, David R

2005

Volltextzugriff (PDF)

Persistence of HIV-1 Transmitted Drug Resistance Mutations

The Journal of infectious diseases, 2013-11, Vol.208 (9), p.1459-1463

2013

Volltextzugriff (PDF)

Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure

The Journal of infectious diseases, 2014-08, Vol.210 (3), p.363-373

2014

Volltextzugriff (PDF)

Life expectancy in people with newly diagnosed epilepsy

Brain (London, England : 1878), 2004-11, Vol.127 (11), p.2427-2432

2004

Volltextzugriff (PDF)

Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study

Journal of antimicrobial chemotherapy, 2009-09, Vol.64 (3), p.667-669

2009

Volltextzugriff (PDF)

Low prevalence of transmitted antiretroviral drug resistance in a large UK HIV-1 cohort

Journal of antimicrobial chemotherapy, 2008-09, Vol.62 (3), p.464-468

2008

Volltextzugriff (PDF)

Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana

Clinical infectious diseases, 2015-09, Vol.61 (6), p.883-891

2015

Volltextzugriff (PDF)

TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy

Clinical infectious diseases, 2020-05, Vol.70 (10), p.2062-2072

2020

Volltextzugriff (PDF)

Clinical characteristics and outcomes of HIV-associated immune complex kidney disease

Nephrology, dialysis, transplantation, 2016-12, Vol.31 (12), p.2099-2107

2016

Volltextzugriff (PDF)

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction

Clinical infectious diseases, 2019-09, Vol.69 (7), p.1136-1143

2019

Volltextzugriff (PDF)

Chronic Kidney Disease Risk in African and Caribbean Populations With HIV

The Journal of infectious diseases, 2018-10, Vol.218 (11), p.1767-1772

2018

Volltextzugriff (PDF)

Foetal Antiepileptic Drug Exposure and Verbal versus Non-Verbal Abilities at Three Years of Age

Brain (London, England : 1878), 2011-02, Vol.134 (2), p.396-404

2011

Volltextzugriff (PDF)

Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring

Journal of antimicrobial chemotherapy, 2018-11, Vol.73 (11), p.3148-3157

2018

Volltextzugriff (PDF)

Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring

Journal of antimicrobial chemotherapy, 2013-06, Vol.68 (6), p.1354-1359

2013

Volltextzugriff (PDF)

Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom

Clinical infectious diseases, 2015-09, Vol.61 (5), p.829-836

2015

Volltextzugriff (PDF)

Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients

Nephrology, dialysis, transplantation, 2012-06, Vol.27 (6), p.2291-2297

2012

Volltextzugriff (PDF)

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

Clinical infectious diseases, 2018-07, Vol.67 (3), p.341-349

2018

Volltextzugriff (PDF)

Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana

Journal of antimicrobial chemotherapy, 2014-01, Vol.69 (1), p.254-261

2014

Volltextzugriff (PDF)

HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK

Journal of antimicrobial chemotherapy, 2016-12, Vol.71 (12), p.3487-3494

2016

Volltextzugriff (PDF)

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

Journal of antimicrobial chemotherapy, 2019-03, Vol.74 (3), p.746-753

2019

Volltextzugriff (PDF)

An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs

Journal of antimicrobial chemotherapy, 2017-07, Vol.72 (7), p.2075-2082

2017

Volltextzugriff (PDF)

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor

Journal of antimicrobial chemotherapy, 2012-04, Vol.67 (4), p.995-1000

2012

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

KollektionOxford University Press Journals Current

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

8 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

COVID-19 infection in people living with HIV

Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial

Viral meningitis

Persistence of HIV-1 Transmitted Drug Resistance Mutations

Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure

Life expectancy in people with newly diagnosed epilepsy

Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study

Low prevalence of transmitted antiretroviral drug resistance in a large UK HIV-1 cohort

Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana

TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy

Clinical characteristics and outcomes of HIV-associated immune complex kidney disease

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction

Chronic Kidney Disease Risk in African and Caribbean Populations With HIV

Foetal Antiepileptic Drug Exposure and Verbal versus Non-Verbal Abilities at Three Years of Age

Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring

Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring

A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy

Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom

Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana

HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor

Aktive Filter

Suchergebnisse filtern